| Pharmaceuticals - Oncology | Innovative cancer therapies focusing on lung, breast, gastrointestinal, genitourinary and rare cancers. | Strong R&D pipeline, global innovation, diagnostic collaborations, and market leadership in key tumor types. | B2B focus on oncologists, hospitals, diagnostic centers. | Targeted therapies and biologics lead margins due to innovation and patient demand. | 487 | 30 | Product sales primarily through hospitals, clinics, and specialist doctors. | Market-driven, with adaptations based on regulatory pricing policies. | Launches of breakthrough oncology drugs, expanding indications, partnerships with medical societies. | Tagrisso, Enhertu, Imfinzi |
| Pharmaceuticals - Biopharmaceuticals | Cardiovascular, respiratory, asthma, and biologic therapies with focus on severe and chronic conditions. | Proprietary drug delivery technology, first-to-market biologics, strong clinical data support competitive differentiation. | B2B healthcare professionals, pulmonologists, cardiologists, specialty hospitals. | Biologics and proprietary inhaler technologies provide premium margins. | 656 | 41 | Sales through medical representatives and partnerships with pharma distributors. | Combination of direct sales and distribution agreements with recurring prescription demand. | Clinical adoption of biologics, inhalers, and cardiovascular drugs, plus broader access initiatives. | Brilinta, Fasenra, Breztri Aerosphere, Synagis |
| Pharmaceuticals - Rare Diseases | Treatments for neurofibromatosis, atypical hemolytic uremic syndrome, paroxysmal nocturnal hemoglobinuria. | First and only approved therapies in many rare indications; strong advocacy collaborations. | B2B focus on rare disease specialists and treatment centers. | Orphan drugs with limited competition generate high margins. | 6 | 0 | Specialty drug sales driven by rare disease centers and hospitals. | Premium pricing with patient support programs and advocacy partnerships. | Expanding labels and awareness programs for rare diseases. | Koselugo, Soliris |
